Cencora to Acquire American Oncology Network to Strengthen Support of Community Oncology
Cencora (NYSE: COR) signed a definitive agreement to acquire American Oncology Network (OTCQX: AONC), a physician-led network of more than 350 oncology providers across 21 states, at a $2.4 billion enterprise value. The deal consists of $2.3 billion at closing plus CVRs of up to $100 million. Cencora already holds roughly 4% of AON; with an equity rollover of up to 25%, it expects to pay about $1.7 billion in cash to reach 75% ownership. The transaction requires regulatory clearances and AON stockholder approval, and Cencora expects it to be accretive to adjusted diluted EPS in the second year post-closing.
Key figures
- Deal Value Usd
- 2400000000
- States
- 21
- Cvr value
- 100000000
- Providers
- more than 350
- Rollover max
- 25% of AON
- Closing value
- 2300000000
- Cencora current stake
- approximately 4%
- Cash outlay if full rollover
- 1700000000
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.